MD, Gulhane Military Medical School, Ankara, Turkey
Gulhane Military Medical School, Ankara, Turkey
Research Fellowship: Division of Neuroradiology, Johns Hopkins University of Medicine, Baltimore; Neuro-Oncology Imaging Fellowship, Neuroradiology, Memorial Sloan Kettering Cancer Center; Nuclear-Oncology Imaging Fellowship, Nuclear Medicine, Memorial Sloan Kettering Cancer Center
Turkish Board of Radiology; Associate Professor of Radiology (Turkish Council of Higher Education); Radiology, licensed in Turkey (Ministry of Health)
I am a radiologist with subspecialty training in both neuro- and nuclear-oncology imaging. I earned an Associate Professorship degree in Turkey and have been practicing radiology for more than 15 years. I joined Memorial Sloan Kettering in 2018.
My practice involves the interpretation of imaging studies of the brain, spine, and neck as well as performing neuro-interventional procedures, such as image-guided lumbar punctures and myelography. Working at MSK is rewarding for me as it allows me to collaborate with an outstanding team to improve the lives of the patients we care for.
My research interests include advanced imaging techniques, such as high-resolution MRI, diffusion and perfusion MRI, and molecular imaging of head and neck cancer. I am currently studying the development of faster and higher-resolution MRI techniques. The greatest impact of these new techniques will be seen in those patients who cannot tolerate lengthy procedures, such as young children and patients requiring anesthesia.
I chose oncologic radiology because it is such a rewarding subspecialty that allows me to make a real difference in my patients’ lives. Early detection of cancer is paramount, however, taking care of patients is more than early detection — it also requires seeing with the eyes of the patients. I strongly believe that empathy and enthusiasm are vital components of healthcare quality.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ahmet Turan Ilica discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at firstname.lastname@example.org.